Call to European public health community: push for sharing rights, know-how and technology

Wemos and EUPHA, the umbrella organization for public health associations and institutes in Europe, call upon public health experts to advocate sharing of patent rights, know-how and technology to maximize the production capacity of Covid-19 vaccines. In a joint statement, the two organizations stress that more certified pharmaceutical companies should be enabled to use their factories to produce vaccines. This is crucial in supplying all parts of the world with enough vaccines to end the corona pandemic as quickly as possible.

Creating awareness

Wemos and EUPHA consider it of utmost importance that all national governments in Europe are aware of the need to maximize the production capacity of vaccines. They must push for effective measures to achieve this at the addresses of the European Commission and World Trade Organization. Members of EUPHA and the wider public health community can help creating this awareness by raising this issue with relevant policy makers in their country.

Crucial steps

In their statement, Wemos and EUPHA explain that two steps are crucial to maximize the production capacity of vaccines: 1) temporary suspension of intellectual property rights, preferably voluntarily, and otherwise through the so-called TRIPS waiver, and 2) the sharing of know-how and technology for vaccine production, through initiatives like the Covid-19 Technology Access Pool (C-TAP) and the mRNA Vaccine Technology Transfer Hub. The statement provides detailed information on the current global manufacturing capacity, recognized issues in expanding that capacity, and the adhering solutions.

Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News items

Our highlights of 2021: seizing momentum for global health


We want everyone, everywhere to receive the health care services they need without suffering financial hardship. The path to achieving that goal is far from paved. However, in 2021 we have seen – and taken – opportunities to push for the structural changes that we envision. We are proud to present our highlights of 2021! 

Continue reading

New coalition agreement: this is what a Dutch Global Health Strategy should look like


The Covid-19 pandemic has strengthened calls for the need for a coherent Dutch Global Health Strategy. Wemos – as one of the founding members of the Dutch Global Health Alliance (DGHA) – is therefore thrilled to see that the Dutch government has included the intention to develop such a Strategy in the new coalition agreement ‘Omzien naar elkaar, vooruitkijken naar de toekomst’. As the Dutch Global Health Alliance, we have a clear position on the topic. Earlier this month, we shared our views in a policy brief that we submitted to the Advisory Council on International Affairs (AIV).

Continue reading